The following questions should be considered before, during and after contemplating the cases:
How can scientists effectively engage the government on matters of biosecurity and vice versa?
Is the recently inaugurated NSABB a sufficient institutional means of self-review for biotechnology research?
What changes to everyday research practice or policy could both maintain the freedom of research inquiry and improve national security?
As research advancements expose potentially dangerous new technologies or techniques, how should these emerging vulnerabilities or threats be addressed?